Stifel Maintains Black Diamond Therapeutics(BDTX.US) With Buy Rating, Cuts Target Price to $16

Futu NewsNov 6 21:37 · Ratings

Express News | Black Diamond Therapeutics Inc : Stifel Cuts Target Price to $16 From $18

BreakingsNov 6 20:03

Black Diamond Therapeutic Analyst Ratings

BenzingaNov 6 17:47 · Ratings

TD Cowen Maintains Black Diamond Therapeutics(BDTX.US) With Buy Rating

Futu NewsNov 6 00:31 · Ratings

Strong Buy Rating for Black Diamond Therapeutics Driven by Financial Stability and Promising Clinical Developments

TipRanksNov 5 23:25 · Ratings

Express News | Black Diamond Therapeutics Inc: Clinical Updates of Bdtx-1535 in Egfrm Nsclc and Regulatory Feedback Expected in Q1 2025

BreakingsNov 5 21:02